527 related articles for article (PubMed ID: 12829785)
1. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.
Boulanger MJ; Chow DC; Brevnova EE; Garcia KC
Science; 2003 Jun; 300(5628):2101-4. PubMed ID: 12829785
[TBL] [Abstract][Full Text] [Related]
2. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
3. Structure of an extracellular gp130 cytokine receptor signaling complex.
Chow D; He X; Snow AL; Rose-John S; Garcia KC
Science; 2001 Mar; 291(5511):2150-5. PubMed ID: 11251120
[TBL] [Abstract][Full Text] [Related]
4. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
5. Theoretical investigation of IL-6 multiprotein receptor assembly.
Menziani MC; Fanelli F; De Benedetti PG
Proteins; 1997 Dec; 29(4):528-44. PubMed ID: 9408949
[TBL] [Abstract][Full Text] [Related]
6. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
[TBL] [Abstract][Full Text] [Related]
7. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
8. In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130.
Chow D; Ho J; Nguyen Pham TL; Rose-John S; Garcia KC
Biochemistry; 2001 Jun; 40(25):7593-603. PubMed ID: 11412113
[TBL] [Abstract][Full Text] [Related]
9. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
[TBL] [Abstract][Full Text] [Related]
10. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6.
Boulanger MJ; Chow DC; Brevnova E; Martick M; Sandford G; Nicholas J; Garcia KC
J Mol Biol; 2004 Jan; 335(2):641-54. PubMed ID: 14672670
[TBL] [Abstract][Full Text] [Related]
12. Compensatory energetic mechanisms mediating the assembly of signaling complexes between interleukin-2 and its alpha, beta, and gamma(c) receptors.
Rickert M; Boulanger MJ; Goriatcheva N; Garcia KC
J Mol Biol; 2004 Jun; 339(5):1115-28. PubMed ID: 15178252
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides mimicking the interleukin-6/gp130 interaction: a two-helix bundle system. Design and conformational studies.
Zaccaro L; Bucci E; Vitale RM; Perretta G; Fattorusso R; Benedetti E; Saviano M; Pedone C
J Pept Sci; 2003 Feb; 9(2):90-105. PubMed ID: 12630694
[TBL] [Abstract][Full Text] [Related]
14. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.
Hammacher A; Wijdenes J; Hilton DJ; Nicola NA; Simpson RJ; Layton JE
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):25-32. PubMed ID: 10600635
[TBL] [Abstract][Full Text] [Related]
15. Shared cytokine signaling receptors: structural insights from the gp130 system.
Boulanger MJ; Garcia KC
Adv Protein Chem; 2004; 68():107-46. PubMed ID: 15500860
[TBL] [Abstract][Full Text] [Related]
16. The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes.
Grötzinger J; Kurapkat G; Wollmer A; Kalai M; Rose-John S
Proteins; 1997 Jan; 27(1):96-109. PubMed ID: 9037715
[TBL] [Abstract][Full Text] [Related]
17. No inhibition of IL-27 signaling by soluble gp130.
Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
[TBL] [Abstract][Full Text] [Related]
18. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.
Aoki Y; Narazaki M; Kishimoto T; Tosato G
Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289
[TBL] [Abstract][Full Text] [Related]
19. Negative modulation of signal transduction via interleukin splice variation.
Denessiouk KA; Denesyuk AI; Johnson MS
Proteins; 2008 May; 71(2):751-70. PubMed ID: 17979192
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11 signals through the formation of a hexameric receptor complex.
Barton VA; Hall MA; Hudson KR; Heath JK
J Biol Chem; 2000 Nov; 275(46):36197-203. PubMed ID: 10948192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]